Full name
PURE CLINICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
71.12.Z - Engineering activities and related technical consultancy
71.20.B - Other technical testing and analysis
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 5,3 | -0,4 | -106,8 |
EBITDA | 5,4 | -0,1 | -102,2 |
Short time liabilities | 0,7 | 0,2 | -76 |
Equity capital | 6 | 6,4 | 7,3 |
Operating profit (EBIT) | 5,4 | -0,2 | -104,2 |
Assets | 9,4 | 6,6 | -29,5 |
Net profit (loss) | 4,3 | -0,4 | -108,4 |
Cash | 6,3 | 1,3 | -80 |
Net income from sale | 13,7 | 6,6 | -52 |
Liabilities and provisions for liabilities | 3,4 | 0,2 | -95,3 |
Working assets | 9,4 | 2,7 | -70,7 |
Depreciation | 0 | 0,1 | -∞ |
% | % | p.p. | |
Profitability of capital | 71,7 | -5,6 | -77,3 |
Equity capital to total assets | 64,1 | 97,6 | 33,5 |
Gross profit margin | 38,7 | -5,5 | -44,2 |
EBITDA Margin | 39 | -1,8 | -40,8 |
Days | Days | Days | |
Short term commitment turnover cycle | 17 | 9 | -8 |
Current financial liquidity indicator | 2.787442445755005 | 17.3439884185791 | 14,5 |
Net dept to EBITDA | -1.182416558265686 | 10.764444351196289 | 12 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane